Kenneth Aldape

National Institutes of Health — United States

Medicine · Health Sciences

141h-index90.5kcitations1.1kworks3.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(497), Cancer Genomics and Diagnostics(148), Meningioma and schwannoma management(116), Epigenetics and DNA Methylation(102), Brain Metastases and Treatment(102)

Publications1.0k total

Supplementary Table 3 from Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor Histopathology
2025Open Access
Supplementary Figure S1 from Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor Histopathology
2025Open Access
Supplementary Figure S5 from Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor Histopathology
2025Open Access
Supplementary Figure S14 from Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor Histopathology
2025Open Access
Data from Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor Histopathology
2025Open Access
Supplementary Figure S9 from Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor Histopathology
2025Open Access
Supplementary Figure S7 from Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor Histopathology
2025Open Access
Supplementary Table 4 from Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor Histopathology
2025Open Access
Supplementary Figure S17 from Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor Histopathology
2025Open Access
Supplementary Figure S15 from Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor Histopathology
2025Open Access
Supplementary Figure S16 from Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor Histopathology
2025Open Access
Supplementary Figure S2 from Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor Histopathology
2025Open Access
Supplementary Figure S10 from Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor Histopathology
2025Open Access
Supplementary Table 2 from Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor Histopathology
2025Open Access
Supplementary Figure S12 from Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor Histopathology
2025Open Access
Supplementary Figure S6 from Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor Histopathology
2025Open Access
Supplementary Table 1 from Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor Histopathology
2025Open Access
Supplementary Figure S11 from Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor Histopathology
2025Open Access
Supplementary Figure S3 from Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor Histopathology
2025Open Access
Supplementary Figure S8 from Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor Histopathology
2025Open Access
page 1 of 51Next →

Frequent Co-authors

Mark R. Gilbert(13), Andreas von Deimling(12), Erik P. Sulman(8), David Jones(7), Guido Reifenberger(7), Michael Weller(7), Pieter Wesseling(7), Jill S. Barnholtz‐Sloan(6), Howard Colman(6), Michael D. Taylor(6), Andrey Korshunov(6), Stefan M. Pfister(6), Daniel J. Brat(6), Raymond Sawaya(6), Michael D. Prados(5), Ludmil B. Alexandrov(5), Minesh P. Mehta(5), Volker Hovestadt(5), Khalida Wani(5), David Capper(5)